This is an external link. Click “OK” to continue.
– Large market partnering program now underway – – Limited COVID-19 impact: Phase III program slated to start in second half of 2021 – – U.S. institutional outreach expanding – TORONTO, CANADA — (January 11, 2021) To our shareholders, As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in … Continued
– Dr. Haut spearheaded AskBio’s recent $4 billion acquisition by Bayer AG – TORONTO, CANADA — (January 7, 2021) – Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced the appointment of Dr. Don Haut to … Continued
Please sign up to our mailing list to receive regular news updates via e-mail.